antibodydepend
enhanc
ade
mechan
virus
dengu
hiv
ebola
gain
entri
target
cell
use
host
antivir
humor
immun
respons
studi
abil
sever
acut
respiratori
syndrom
coronaviru
sarscov
use
ade
mechan
enhanc
infect
toward
cell
hematopoiet
lineag
found
heatinactiv
immun
serum
rodent
vaccin
recombin
nativ
fulllength
spike
protein
trimer
trigger
infect
human
immun
cell
monocyt
b
cell
line
sarscov
spike
pseudotyp
particl
sarscovpp
occurr
antibodymedi
infect
human
raji
b
cell
investig
use
live
sarscov
similarli
result
obtain
sarscovpp
antisarscov
spike
serum
mock
immuneserum
induc
massiv
increas
sarscov
viral
gene
nucleocapsid
viral
protein
membran
nucleocapsid
raji
b
cell
reveal
immunostain
rel
low
howev
signific
percentag
raji
cell
get
infect
antibodymedi
infect
allow
direct
assess
product
replic
convent
cytopath
assay
titrat
taken
togeth
data
suggest
sarscov
abl
enter
human
immun
cell
via
antibodymedi
pathway
immunolog
consequ
infect
investig
product
replic
cytokin
secret
profil
cell
death
etc
data
rais
reason
concern
regard
use
sarscov
vaccin
human
pave
way
studi
focus
role
immunemedi
infect
phenomenon
sar
pathogenesi
